131 related articles for article (PubMed ID: 38296626)
21. Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment.
Kim H; Park S; Han KY; Lee N; Kim H; Jung HA; Sun JM; Ahn JS; Ahn MJ; Lee SH; Park WY
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36787939
[TBL] [Abstract][Full Text] [Related]
22. [Expression levels of co-inhibitory molecules CTLA-4, LAG-3, PD-1 and CD39 on CD4⁺ T cells correlate with progression of non-small cell lung cancer].
Wei T; Zhang J; Wu Y; Zhang D; Lu L; Shen Q
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):424-9. PubMed ID: 25241783
[TBL] [Abstract][Full Text] [Related]
23. CD4
Kagamu H; Kitano S; Yamaguchi O; Yoshimura K; Horimoto K; Kitazawa M; Fukui K; Shiono A; Mouri A; Nishihara F; Miura Y; Hashimoto K; Murayama Y; Kaira K; Kobayashi K
Cancer Immunol Res; 2020 Mar; 8(3):334-344. PubMed ID: 31871122
[TBL] [Abstract][Full Text] [Related]
24. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
[TBL] [Abstract][Full Text] [Related]
25. The differentiation of new human CD303
Zhong Q; Lu Y; Xu W; Rong Z; Chang X; Qin L; Chen X; Zhou F
Int Immunopharmacol; 2021 Oct; 99():107983. PubMed ID: 34298400
[TBL] [Abstract][Full Text] [Related]
26. Effect of TGF-β1 on blood CD4
Hu Y; Qi W; Sun L; Zhou H; Zhou B; Yang Z
Exp Ther Med; 2018 Aug; 16(2):1403-1410. PubMed ID: 30112067
[TBL] [Abstract][Full Text] [Related]
27. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
[TBL] [Abstract][Full Text] [Related]
29. T lymphocyte subsets and PD-1 expression on lymphocytes in peripheral blood of patients with non-small cell lung cancer.
Chen T; Chen H; Lu W; Yao Y
Medicine (Baltimore); 2022 Oct; 101(42):e31307. PubMed ID: 36281084
[TBL] [Abstract][Full Text] [Related]
30. Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.
Rocha P; Rodrigo M; Moliner L; Menendez S; Masfarré L; Navarro N; Del Rey-Vergara R; Galindo-Campos M; Taus Á; Giner M; Sanchez I; Rodríguez-Fuster A; Aguiló R; Chalela R; Sánchez-Font A; Belda J; Curull V; Pijuan L; Casadevall D; Clavé S; Bellosillo B; Perera-Bel J; Comerma L; Arriola E
Lung Cancer; 2023 Jul; 181():107257. PubMed ID: 37263182
[TBL] [Abstract][Full Text] [Related]
31. Blood immune cell biomarkers in lung cancer.
Riemann D; Cwikowski M; Turzer S; Giese T; Grallert M; Schütte W; Seliger B
Clin Exp Immunol; 2019 Feb; 195(2):179-189. PubMed ID: 30246868
[TBL] [Abstract][Full Text] [Related]
32. [Design of a multicolor panel to assess intracellular and surface molecules by flow cytometry].
Mateus J; Lasso P; González JM; Puerta CJ; Cuéllar A
Biomedica; 2013; 33(4):660-72. PubMed ID: 24652220
[TBL] [Abstract][Full Text] [Related]
33. PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.
Shen C; Liu C; Zhang Z; Ping Y; Shao J; Tian Y; Yu W; Qin G; Liu S; Wang L; Zhang Y
Front Immunol; 2021; 12():680055. PubMed ID: 34194433
[TBL] [Abstract][Full Text] [Related]
34. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
35. Evodiamine suppresses non-small cell lung cancer by elevating CD8
Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
[TBL] [Abstract][Full Text] [Related]
36. OMIP-060: 30-Parameter Flow Cytometry Panel to Assess T Cell Effector Functions and Regulatory T Cells.
Liechti T; Roederer M
Cytometry A; 2019 Nov; 95(11):1129-1134. PubMed ID: 31334913
[TBL] [Abstract][Full Text] [Related]
37. Double-negative (CD27
Centuori SM; Gomes CJ; Kim SS; Putnam CW; Larsen BT; Garland LL; Mount DW; Martinez JD
J Transl Med; 2018 Feb; 16(1):30. PubMed ID: 29448960
[TBL] [Abstract][Full Text] [Related]
38. Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.
Zikos TA; Donnenberg AD; Landreneau RJ; Luketich JD; Donnenberg VS
Cancer Immunol Immunother; 2011 Jun; 60(6):819-27. PubMed ID: 21373990
[TBL] [Abstract][Full Text] [Related]
39. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
40. Identification of circulating regulatory T lymphocytes with membrane markers - a new multiparameter flow cytometry protocol.
Piekarska A; Pérès M; Toton M; Kulczycka M; Lewandowski K; Vergez F
Folia Histochem Cytobiol; 2021; 59(2):75-85. PubMed ID: 34097299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
